Wed. 6 Mar 2024, 7:32am ET
Benzinga
Earnings, News
WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.23) by 34.78 percent. This is a 68.09 percent increase over losses of $(0.47) per share from the same period last year. The company reported quarterly sales of $29.06 million which beat the analyst consensus estimate of $19.86 million by 46.30 percent. This is a 2.25K percent increase over sales of $1.24 million the same period last year.